INKT icon

MiNK Therapeutics
INKT

Overview Fund Activity

21 hedge funds and large institutions have $565K invested in MiNK Therapeutics in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.

Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TRCT
1
Tower Research Capital (TRC)
New York
$3.76K
2
Northern Trust
2
Northern Trust
Illinois
$7.97K
3
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$172
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$227
5
BlackRock
5
BlackRock
New York
$61.5K

Top Sellers

1
CAPTRUST Financial Advisors
1
CAPTRUST Financial Advisors
North Carolina
$0
2
TSS
2
Two Sigma Securities
New York
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$70.9K
4
UBS Group
4
UBS Group
Switzerland
$1.98K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$67K
Name Holding Trade Value Shares
Change 		Shares
Change %
CCM
26
Chilton Capital Management
Texas
– -$232 -31 Closed
CA
27
Clearstead Advisors
Ohio
– -$110 -15 Closed
JIP
28
Jaffetilchin Investment Partners
Florida
– -$1 – –
1
2